Ru-Tuss in the symptomatic treatment of allergic rhinitis.
In the treatment of allergic rhinitis with a placebo only one symptom, nasal itching, was reduced significantly. Where Ru-Tuss tablets were used, all symptoms improved and statistically significant reduction of  symptoms were obtained for lacrimation, nasal itching, sneezing, itching of the mouth, itching of the pharynx, rhinorrhea and the condition of the nasal mucosa. Ridit analysis was used to evaluate differences between the Ru-Tuss Tablet and the placebo treated groups.
D001285:Atropine / Q000627:therapeutic use*; D002744:Chlorpheniramine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D010656:Phenylephrine / Q000627:therapeutic use*; D010665:Phenylpropanolamine / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D012601:Scopolamine / Q000627:therapeutic use*
D010656:Phenylephrine; D010665:Phenylpropanolamine; D002744:Chlorpheniramine; D001285:Atropine; D012601:Scopolamine